Cargando…

1431. Dynamics of Antibiotic Prescription Rate Following Pneumococcal Conjugate Vaccine (PCV) Implementation in Children <2 Years Old: Comparison Between High and Low Prescribing Clinics in Two Different Ethnic Groups

BACKGROUND: Antibiotic overuse is common among pediatricians. Since PCV reduces respiratory infections, a resultant reduction in antibiotic consumption was expected. We speculated that the decline in dispensed antibiotic prescription (DAP) rates will be greater among high antibiotic user clinics (HU...

Descripción completa

Detalles Bibliográficos
Autores principales:	Danino, Dana, Givon-Lavi, Noga, Ben-Shimol, Shalom, Greenberg, David, Dagan, Ron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254078/ http://dx.doi.org/10.1093/ofid/ofy210.1262

Ejemplares similares

Antibiotic Prescription Rates in Children <24 Months Old Following PCV7/PCV13 Sequential Implementation
por: Dagan, Ron, et al.
Publicado: (2017)

1433. Association Between Impact of Pneumococcal Conjugate Vaccines (PCVs) on Acute Respiratory Infections Rates and Impact on Antibiotic Consumption Rates in Young Children
por: Dagan, Ron, et al.
Publicado: (2018)

2903. Post PCV13 Dynamics of NonVaccine Serotype (NVT): Disproportionate Increase of the Additional PCV20 Candidate Serotypes in Respiratory and Invasive Disease in Young Children
por: Ben-Shimol, Shalom, et al.
Publicado: (2019)

Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines
por: Ben-Shimol, Shalom, et al.
Publicado: (2021)

1888. A Nationwide Outbreak of Invasive Pneumococcal Disease (IPD) Caused by a Novel Streptococcus Pneumoniae Serotype 2 (SP2) Clone in the PCV13 Era, in Israel
por: Dagan, Ron, et al.
Publicado: (2019)

Decline in Pneumococcal Disease in Young Children during the COVID-19 Pandemic in Israel Associated with Suppression of seasonal Respiratory Viruses, despite Persistent Pneumococcal Carriage: A Prospective Cohort Study
por: Danino, Dana, et al.
Publicado: (2021)

Impact of pneumococcal conjugate vaccines introduction on antibiotic resistance of Streptococcus pneumoniae meningitis in children aged 5 years or younger, Israel, 2004 to 2016
por: Ben-Shimol, Shalom, et al.
Publicado: (2018)

Characterization of children younger than 5 Years of age with severe community-acquired alveolar pneumonia (CAAP) requiring Pediatric Intensive Care Unit (PICU) admission
por: Feinstein, Yael, et al.
Publicado: (2020)

Disproportionate reduction in respiratory vs. non-respiratory outpatient clinic visits and antibiotic use in children during the COVID-19 pandemic
por: Givon-Lavi, Noga, et al.
Publicado: (2022)

Community Prescribing and Resistant Streptococcus pneumoniae
por: Barkai, Galia, et al.
Publicado: (2005)

1940. Real-Life Impact of Pneumococcal Conjugate Vaccines (PCVs) on Hospitalization of Young Children with RSV-Associated Community-acquired Alveolar Pneumonia (CAAP)
por: Dagan, Ron, et al.
Publicado: (2023)

Comparison of early onset sepsis and community-acquired late onset sepsis in infants less than 3 months of age
por: Bulkowstein, Shlomi, et al.
Publicado: (2016)

Influence of Pneumococcal Vaccines and Respiratory Syncytial Virus on Alveolar Pneumonia, Israel
por: Weinberger, Daniel M., et al.
Publicado: (2013)

Dynamics of invasive pneumococcal disease in infants < 2 years old following PCV7/13 implementation using two infant and a booster dose schedule: evidence for indirect protection of young infants, Israel, 2004 to 2019
por: Ben-Shimol, Shalom, et al.
Publicado: (2023)

Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel
por: Rokney, Assaf, et al.
Publicado: (2018)

Evaluating post-vaccine expansion patterns of pneumococcal serotypes
por: Phillips, Maile T., et al.
Publicado: (2020)

Association Between the Decline in Pneumococcal Disease in Unimmunized Adults and Vaccine-Derived Protection Against Colonization in Toddlers and Preschool-Aged Children
por: Weinberger, Daniel M, et al.
Publicado: (2019)

2203. Involvement of Respiratory Viruses in Community-Acquired Alveolar Pneumonia (CAAP) in Children < 5 Years in Southern Israel, Before and During the COVID-19 Pandemic
por: Danino, Dana, et al.
Publicado: (2022)

Association of Human Metapneumovirus with Radiologically Diagnosed Community-Acquired Alveolar Pneumonia in Young Children
por: Wolf, Dana G., et al.
Publicado: (2010)

Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study
por: Lo, Stephanie W, et al.
Publicado: (2019)

The COVID-19 pandemic as an opportunity for unravelling the causative association between respiratory viruses and pneumococcus-associated disease in young children: a prospective study
por: Dagan, Ron, et al.
Publicado: (2023)

2618. Four Respiratory Viruses are Involved in the Majority of Community-Acquired Alveolar Pneumonia (CAAP) Episodes in Children < 5 Years
por: Dagan, Ron, et al.
Publicado: (2023)

Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants
por: Perdrizet, Johnna, et al.
Publicado: (2020)

Pneumococcal Meningitis in Adults after Introduction of PCV7 and PCV13, Israel, July 2009–June 2015
por: Regev-Yochay, Gili, et al.
Publicado: (2018)

Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to the 10-Valent Pneumococcal Conjugate Vaccine (PCV10) in Italy
por: Ansaldi, Filippo, et al.
Publicado: (2020)

651. Implementing a Multiplex-PCR Test for the Diagnosis of Acute Gastroenteritis in Hospitalized Children, Are All Enteric Viruses the Same?
por: Danino, Dana, et al.
Publicado: (2023)

Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in Germany
por: van der Linden, Mark, et al.
Publicado: (2016)

Effectiveness of BNT162b2 Vaccination During Pregnancy in Preventing Hospitalization for Severe Acute Respiratory Syndrome Coronavirus 2 in Infants
por: Danino, Dana, et al.
Publicado: (2023)

Impact of Switch Options on the Economics of Pneumococcal Conjugate Vaccine (PCV) Introduction in Indonesia
por: Suwantika, Auliya A., et al.
Publicado: (2020)

1431. Evaluating Physician Decision Making in Inpatient Antibiotic Prescription for Suspected Urinary Tract Infection
por: Arar, Celine, et al.
Publicado: (2021)

Effectiveness of 13-pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease in children in the Dominican Republic
por: Tomczyk, Sara, et al.
Publicado: (2018)

Invasive pneumococcal surveillance to assess the potential benefits of extended spectrum conjugate vaccines (PCV15/PCV20) in older adults
por: Humphreys, Hilary, et al.
Publicado: (2023)

Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants”
por: Gómez, Jorge A., et al.
Publicado: (2021)

What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae?
por: Colijn, Caroline, et al.
Publicado: (2010)

1480. Incidence of Non-Invasive Pneumococcal Pneumonia in Children in the United States before and after Introduction Pneumococcal Conjugate Vaccines (PCV7 and PCV13) during 1998-2018
por: Hu, Tianyan, et al.
Publicado: (2020)

The Impact of Pneumococcal Conjugate Vaccine (PCV) Coverage Heterogeneities on the Changing Epidemiology of Invasive Pneumococcal Disease in Switzerland, 2005–2019
por: Oyewole, Oluwaseun Rume-Abiola, et al.
Publicado: (2021)

2703. Pneumococcal Carriage of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Non-PCV13 Serotypes among Greek Children Vaccinated with PCV13 in a 3 + 1 Schedule During the First 6 years after the Fourth Dose of PCV13
por: Syrogiannopoulos, George A, et al.
Publicado: (2019)

Initial Effects of the National PCV7 Childhood Immunization Program on Adult Invasive Pneumococcal Disease in Israel
por: Regev-Yochay, Gili, et al.
Publicado: (2014)

1470. Epidemiology of Invasive Pneumococcal Disease (IPD) Following 18 years of Pneumococcal Conjugate Vaccine (PCV) Use in the United States
por: Pilishvili, Tamara, et al.
Publicado: (2020)

Exploring the evidence behind the comparable impact of the pneumococcal conjugate vaccines PHiD-CV and PCV13 on overall pneumococcal disease
por: Izurieta, Patricia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1ogq396unon2o2l7voil95pdh0